Salona Global Medical Device Corp (LNDZF) Financial Statements (2025 and earlier)

Company Profile

Business Address SUITE 2700,
VANCOUVER, BC V6E 4E5
State of Incorp. BC
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
11/30/2022
Q3
8/31/2022
Q2
5/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,0531,3982,3433,1396,9386,877
Cash and cash equivalent1,0531,3982,3433,1396,9386,877
Receivables9,98610,9807,4357,7977,8737,227
Inventory, net of allowances, customer advances and progress billings12,13213,3496,6948,5907,8736,222
Inventory12,13213,3496,6948,5907,8736,222
Prepaid expense2,2031,812321479633560
Other undisclosed current assets   1,353   
Total current assets:25,37427,53918,14720,00523,31720,885
Noncurrent Assets
Operating lease, right-of-use asset11,49011,6697,7647,8784,3344,292
Property, plant and equipment3,8433,9433,3063,0691,5351,496
Long-term investments and receivables, including: 142172192  
Accounts and financing receivable, after allowance for credit loss  142172192  
Other undisclosed long-term investments and receivables      
Intangible assets, net (including goodwill)26,33525,83522,72121,95218,25018,259
Goodwill16,14315,25113,69512,54410,55410,554
Intangible assets, net (excluding goodwill)10,19210,5849,0269,4087,6957,704
Prepaid expense 241437274   
Restricted cash and investments608596566565501483
Total noncurrent assets:42,51842,62134,80233,65624,61924,530
TOTAL ASSETS:67,89270,16052,94953,66147,93745,416
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,91810,0986,1226,1395,7774,036
Accounts payable7,2508,1834,9223,7235,4633,635
Accrued liabilities2,6681,9151,2002,416314401
Debt9,4649,034198194185176
Other liabilities2,1524,0131,3352,0661,8211,447
Other undisclosed current liabilities18,47622,73024,74920,07217,2518,280
Total current liabilities:40,01045,87432,40428,47125,03413,939
Noncurrent Liabilities
Long-term debt and lease obligation7647415325874,9074,858
Long-term debt, excluding current maturities764741532587613634
Liabilities, other than long-term debt7,7237,7276,0076,027  
Operating lease, liability7,7237,7276,0076,0274,2954,224
Other undisclosed noncurrent liabilities    2,425(2,358)(2,297)
Total noncurrent liabilities:8,4878,4686,5399,0396,8446,785
Total liabilities:48,49754,34238,94337,51031,87820,724
Equity
Equity, attributable to parent, including:19,39515,81814,00616,15116,05924,692
Common stock39,68039,61038,97038,76738,59338,391
Additional paid in capital9,4539,1558,4738,0427,6617,457
Accumulated other comprehensive income2,0751,7511,6469681,048629
Accumulated deficit(49,051)(52,040)(50,924)(47,692)(46,163)(36,531)
Other undisclosed equity, attributable to parent17,23817,34115,84116,06414,91914,745
Total equity:19,39515,81814,00616,15116,05924,692
TOTAL LIABILITIES AND EQUITY:67,89270,16052,94953,66147,93745,416

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
11/30/2022
Q3
8/31/2022
Q2
5/31/2022
Q1
Revenues19,64716,57510,68310,54810,04410,049
Cost of revenue
(Cost of Product and Service Sold)
(12,379)(10,943)(6,587)(7,052)(7,016)(6,406)
Gross profit:7,2685,6324,0963,4953,0293,642
Operating expenses(8,283)(8,122)(4,792)(4,036)(3,338)(2,876)
Operating income (loss):(1,015)(2,490)(696)(541)(310)766
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
(0)32(14)(0)0
Interest and debt expense(641)(454)(278)(227)(150)(132)
Income (loss) from continuing operations before equity method investments, income taxes:(1,657)(2,941)(973)(781)(460)634
Other undisclosed income (loss) from continuing operations before income taxes4,6551,828(654)(809)(9,202)(3,859)
Income (loss) from continuing operations before income taxes:2,998(1,114)(1,626)(1,590)(9,662)(3,225)
Income tax expense (benefit)(10)(2)(36)623059
Income (loss) from continuing operations:2,988(1,116)(1,663)(1,529)(9,632)(3,166)
Loss before gain (loss) on sale of properties:(9,632)(3,166)
Net income (loss) available to common stockholders, diluted:2,988(1,116)(1,663)(1,529)(9,632)(3,166)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
11/30/2022
Q3
8/31/2022
Q2
5/31/2022
Q1
Net income (loss):2,988(1,116)(1,663)(1,529)(9,632)(3,166)
Comprehensive income (loss):2,988(1,116)(1,663)(1,529)(9,632)(3,166)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent324105(42)(80)419(377)
Comprehensive income (loss), net of tax, attributable to parent:3,313(1,011)(1,705)(1,609)(9,213)(3,544)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: